Description
Tesamorelin — GHRH(1-44) Analogue
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH 1-44) carrying a trans-3-hexenoyl N-terminal modification. It is supplied for in vitro laboratory research only.
Research context
Preclinical literature has examined this analogue in GHRH receptor (GHRHR) binding assays and pituitary cell culture models of receptor-mediated cAMP pathway activation. Comparative studies have characterised its structural stability relative to native GHRH(1-44) in in vitro model systems.
Specification
- Available sizes: 5mg · 10mg
- Form: lyophilised powder
- Purity: ≥99% (HPLC)
- Testing: independently lot-tested by Horizon Analytical · Certificate of Analysis per lot
For laboratory research use only. This material is supplied to qualified researchers and institutions for in vitro investigational use. It is not a drug, food, cosmetic or medical device. It is not intended for human or veterinary use, for diagnosis, treatment, cure or prevention of any disease, or for any use outside a controlled laboratory environment. No statement on this site has been evaluated by the Food and Drug Administration. Keep out of reach of children.
Related Research
Compound family: HGH, Sermorelin, CJC-1295 with DAC, IGF-1 LR3
Browse: Growth Factor & Endocrine Research · All Research Peptides
Reconstitution & Lab Testing: All products independently tested by Horizon Analytical. See our Reconstitution & Lab Testing FAQ. Reconstitution typically requires BAC Water.
Reviews
No reviews yet — be the first researcher to share feedback on this peptide.